首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   15817篇
  免费   3166篇
  国内免费   266篇
耳鼻咽喉   701篇
儿科学   608篇
妇产科学   308篇
基础医学   840篇
口腔科学   399篇
临床医学   2076篇
内科学   3641篇
皮肤病学   581篇
神经病学   1595篇
特种医学   631篇
外科学   3836篇
综合类   185篇
现状与发展   2篇
一般理论   1篇
预防医学   1080篇
眼科学   546篇
药学   695篇
中国医学   79篇
肿瘤学   1445篇
  2024年   78篇
  2023年   546篇
  2022年   210篇
  2021年   497篇
  2020年   820篇
  2019年   343篇
  2018年   836篇
  2017年   749篇
  2016年   917篇
  2015年   859篇
  2014年   1173篇
  2013年   1369篇
  2012年   749篇
  2011年   713篇
  2010年   878篇
  2009年   1056篇
  2008年   631篇
  2007年   492篇
  2006年   540篇
  2005年   418篇
  2004年   311篇
  2003年   272篇
  2002年   274篇
  2001年   256篇
  2000年   186篇
  1999年   252篇
  1998年   306篇
  1997年   296篇
  1996年   352篇
  1995年   313篇
  1994年   191篇
  1993年   154篇
  1992年   167篇
  1991年   186篇
  1990年   125篇
  1989年   167篇
  1988年   132篇
  1987年   117篇
  1986年   111篇
  1985年   133篇
  1984年   117篇
  1983年   96篇
  1982年   97篇
  1981年   65篇
  1980年   69篇
  1979年   49篇
  1978年   68篇
  1977年   64篇
  1975年   58篇
  1972年   45篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.

Background

Multiple myeloma (MM) is a hematologic malignancy of plasma cell origin. MM primarily affects bone marrow, but extramedullary sites can also be involved. Myelomatous pleural effusion (MPE) is an atypical and rare complication of MM. We aimed to systematically study the incidence and clinicopathologic profile of patients with MPE in a real-world setting.

Patients and Methods

In this retrospective study, 415 consecutive patients with MM managed at a tertiary care center in North India during a study period of January 1, 2010 to December 31, 2015 were evaluated for MPE. The patients with MPE were analyzed for their clinical profile, diagnosis, treatment, and outcomes.

Results

Of these 415 patients, 11 (2.65%) patients had MPE. The median age of the study population was 50 years with male preponderance. The majority of these patients had immunoglobin (Ig)G Kappa disease. All patients had higher than International Staging System stage I disease. MPE was a presenting feature at MM diagnosis in 45.45% (n = 5) of the patients, whereas the rest developed MPE during follow-up. MPE presented predominantly (81.8%) as a unilateral effusion. Concurrent extramedullary involvement at other site was seen in 45.45% (n = 5), with 3 (27%) patients having concurrent myelomatous ascites. Six of these were managed aggressively, whereas 5 patients opted for palliation. The outcomes were dismal (90.9% mortality), with a median survival of 2.47 months.

Conclusion

MPE is a rare entity, and positive outcomes of therapy remain low with dismal prognosis.  相似文献   
6.
7.
8.
9.
Intussusception is a very rare cause of intestinal obstruction in neonates. It is of extremely rare occurrence among premature neonates. We present a case of 11-day-old premature neonate who presented with abdominal distension, intolerance to feeds, vomiting, significant bilious aspirate and bleeding per rectum. The initial diagnosis of necrotizing enterocolitis (NEC) led to a delay in the diagnosis. On exploratory laparotomy, it turned out to be a case of ileo-colic intussusception with Meckel''s diverticulum as a lead point. This site of intussusception (ileo-colic) and presence of a lead point among premature neonate is of exceedingly rare occurrence and very few such cases have been reported.In this article, the published work about clinical features and management on intussusceptions in premature neonates has been reviewed. The authors intend to highlight the difficulty in distinguishing the NEC and intussusception. Subtle clinical and radiological features which can help in differentiating the two conditions have been emphasized. This can avoid the delay in diagnosis and management which can prove critical. High index of suspicion with timely intervention is the key for optimizing outcome. A diagnosis of intussusception should always be considered in any preterm infant with suspected NEC.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号